Table 2 Comparison of primary and secondary clinical outcomes between the treated and control groups
Variables | Total (n = 355) | Control (n = 174) | Treated (n = 181) | p value | Adjusted p value* |
|---|---|---|---|---|---|
Hospital mortality, n (%) | 117 (33) | 62 (36) | 55 (30) | 0.348 | 0.621 |
ICU mortality, n (%) | 72 (20) | 39 (22) | 33 (18) | 0.397 | 0.621 |
ICU LOS, median (Q1, Q3) | 5.74 (3.37, 10.46) | 5.79 (3.34, 11.17) | 5.6 (3.39, 9.8) | 0.617 | 0.632 |
Hospital LOS, median (Q1, Q3) | 11.62 (6.61, 18.51) | 12.01 (7.63, 20.76) | 10.83 (5.81, 16.65) | 0.129 | 0.621 |
Duration of vasopressor use, median (Q1, Q3) | 2.69 (1.61, 4.02) | 2.74 (1.71, 4.05) | 2.39 (1.31, 3.79) | 0.216 | 0.621 |
CRRT days, median (Q1, Q3) | 4.35 (2.97, 8.85) | 3.45 (2.84, 8.1) | 7.17 (4.35, 8.85) | 0.435 | 0.621 |
MV duration, median (Q1, Q3) | 5.05 (2.99, 9.9) | 5.61 (3.62, 9.92) | 4.84 (2.88, 9.75) | 0.632 | 0.632 |
Vasopressor free days in 28Â days, median (Q1, Q3) | 25.23 (10.15, 28) | 25.22 (8.6, 27.94) | 25.23 (12.6, 28) | 0.585 | 0.621 |
MV free in 28Â days, median (Q1, Q3) | 25.26 (7.18, 28) | 24.37 (5.86, 28) | 25.99 (8.47, 28) | 0.411 | 0.621 |
CRRT free in 28Â days, median (Q1,Q3) | 28 (11.48, 28) | 28 (10.22, 28) | 28 (13.42, 28) | 0.366 | 0.632 |